1. COVID-19 retningslinje (2024v30)

   Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem.

   Ændringer siden version 29:

   Indikationer for COVID-19 test er tilføjet.

   333 KB, Uploadet 28. oktober 2024

2. Antivirale midler til SARS-CoV-2 (2022)

   Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.

   1.1 MB, Uploadet 11. januar 2022

3. COVID-19 følger (2021)

   Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.

   158 KB, Uploadet 24. september 2021

1. Aktuelle tal (SSI)

   https://experience.arcgis.com/experience/220fef27d07d438889d651cc2e00076c/page/Covid-19-Regionalt

2. Aktuelle tal (ECDC)

   https://erviss.org/

3. Aktuelle tal (WHO)

   https://covid19.who.int

4. Mortalitetsmonitorering (EuroMOMO)

   https://euromomo.eu/graphs-and-maps

5. Genomic epidemiology of SARS-CoV-2 (Nextstrain)

   https://nextstrain.org/ncov/open/global

6. Liverpool COVID-19 drug interactions

   https://covid19-druginteractions.org/checker

7. Standford Coronavirus antiviral & resistance database

   https://covdb.stanford.edu

1. SSI's epidemiologiske rapporter med særligt fokus på udvalgte perspektiver af COVID-19 udbruddet

   https://covid19.ssi.dk/analyser-og-prognoser/fokusrapporter

2. Sundhedsstyrelsens Nationale Kliniske Anbefaling: Brug af lægemidler ved forebyggelse og behandling af COVID-19

   https://www.sst.dk/da/udgivelser/2023/nka-brug-af-laegemidler-ved-forebyggelse-og-behandling-af-covid-19

Se flere resultater

1. Correction: Integrating psychosocial health into disaster risk management: Insights from COVID-19 in Durán, Ecuador

   PLoS One Infectious Diseases

   Tilføjet 7. juli 2026
2. Social vulnerability and spatial patterns of COVID-19 mortality: Global implications for respiratory health equity

   PLoS One Infectious Diseases

   Tilføjet 2. juli 2026
3. Emergency department visits and disease patterns during and after the COVID-19 lockdown

   PLoS One Infectious Diseases

   Tilføjet 27. juni 2026
4. Factors associated with multiple births in the United Kingdom during COVID-19: A cross-sectional survey

   PLoS One Infectious Diseases

   Tilføjet 27. juni 2026
5. Editorial Note: The impact of COVID-19 on opioid toxicity deaths for people who experience incarceration compared to the general population in Ontario: A whole population data linkage study

   PLoS One Infectious Diseases

   Tilføjet 25. juni 2026
6. Severity-dependent metabolic rewiring in COVID-19 based on untargeted metabolomic profiling of patient plasma

   PLoS One Infectious Diseases

   Tilføjet 25. juni 2026
7. Correction: The Covid-19 pandemic in Sweden: Prolonged and unevenly distributed effects on the volume of pediatric anesthesia and surgery demonstrated by data from the Swedish Perioperative Register

   PLoS One Infectious Diseases

   Tilføjet 19. juni 2026
8. “The impact of COVID-19 on employee productivity and the future of remote work”

   PLoS One Infectious Diseases

   Tilføjet 18. juni 2026
9. Etiology of severe acute respiratory infections among adults in northern Thailand using multiplex PCR: A post-COVID-19 surveillance study (2023–2024)

   PLoS One Infectious Diseases

   Tilføjet 10. juni 2026
10. Changes in tobacco sales before, during, and after the COVID-19 pandemic in Japan: An interrupted time series analysis

    PLoS One Infectious Diseases

    Tilføjet 6. juni 2026
11. Predicting severe COVID-19 disease in adults: A single-centre cohort study during the first three pandemic waves in 2020–2021 in Vilnius, Lithuania

    PLoS One Infectious Diseases

    Tilføjet 30. maj 2026
12. Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19

    PLoS One Infectious Diseases

    Tilføjet 19. maj 2026
13. A solo journey in the shadow of a double-edged pandemic: A qualitative study of women’s experience of being pregnant during the COVID-19 pandemic

    PLoS One Infectious Diseases

    Tilføjet 16. maj 2026
14. Measurement properties of the 30-second sit-to-stand test in post COVID-19 condition: Results from the PYCNOVID randomised controlled trial

    PLoS One Infectious Diseases

    Tilføjet 13. maj 2026
15. Life lost due to the COVID-19 pandemic: A model-based cohort analysis of mortality displacement in the registered population of England

    PLoS One Infectious Diseases

    Tilføjet 8. maj 2026
16. Differences in the long-term course of post-COVID-19 symptoms in adults and children across epidemic periods: A retrospective cohort study in Japan, 2020–2024

    PLoS One Infectious Diseases

    Tilføjet 8. maj 2026
17. Understanding why people value working from home or hybrid workplace flexibility a study of preferences during the COVID-19 pandemic

    PLoS One Infectious Diseases

    Tilføjet 5. maj 2026
18. Poldip2 deficiency attenuates lung disease severity in a mouse model of COVID-19

    PLoS One Infectious Diseases

    Tilføjet 29. april 2026
19. The impact of COVID-19 vaccination on long-term risk of new-onset atrial fibrillation/flutter after COVID-19 infection: A retrospective cohort study

    PLoS One Infectious Diseases

    Tilføjet 26. april 2026
20. Relationships between pre-pandemic mental health, sociodemographic factors and health behaviours in older adults during the acute onset of COVID-19 in Australia: A descriptive analysis

    PLoS One Infectious Diseases

    Tilføjet 24. april 2026